MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find attached transcript of earnings conference call held on 1-Feb.-2024 at 12.00 Noon (IST).03-02-2024
03-02-2024
MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of confirmation letter for duplicate share certificate02-02-2024
MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Please find attached letter comprising weblink of audio recording of Earnings Conference Call held on 1st February 2024 on unaudited consolidated and standalone financial results for Q-3 FY 2024 of the company .01-02-2024
MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Morepen Laboratories Limited Q 3 FY 2024 EBITDA surges by 151% , Net Profit record a remarkable 256% Growth.01-02-2024
MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
PFA letter comprising details of loss of share certificates.01-02-2024
MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached copy of newspaper publication of Q-3 FY 2024 Results.01-02-2024
MOREPEN LABORATORIES LTD. - 500288 - Details - Senior Management Personnel (Ref. Outcome Of Board Meeting Dated 31St January 2024)
Please find attached details.01-02-2024
MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached Earnings Presentation Q3 FY 24 - January 24.31-01-2024
MOREPEN LABORATORIES LTD. - 500288 - Board Meeting Outcome for Unaudited Financial Results For Q3 FY 24 And Intimation Of Senior Management Personnel
Unaudited Financial Results for Q3 FY 24 and intimation of Senior Management Personnel.31-01-2024
MOREPEN LABORATORIES LTD. - 500288 - Results - Q3 FY 2024
Please find enclosed Q-3 results along with LLR.31-01-2024